Found: 8
Select item for more details and to access through your institution.
Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 1, p. 184, doi. 10.1093/jac/dkq395
- By:
- Publication type:
- Article
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 1, p. 118
- By:
- Publication type:
- Article
Undetectable HIV-1 RNA load with the Cobas TaqMan v1.0 in a patient diagnosed at the time of primary HIV-1 infection.
- Published in:
- Journal of Medical Virology, 2010, v. 82, n. 11, p. 1816, doi. 10.1002/jmv.21827
- By:
- Publication type:
- Article
Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey).
- Published in:
- AIDS & Behavior, 2018, v. 22, n. 10, p. 3264, doi. 10.1007/s10461-018-2077-6
- By:
- Publication type:
- Article
Simplification Therapy with Once-Daily Emtricitabine, Didanosine, and Efavirenz in HIV-1--Infected Adults with Viral Suppression Receiving a Protease Inhibitor--Based Regimen: A Randomized Trial.
- Published in:
- Journal of Infectious Diseases, 2005, v. 191, n. 6, p. 830
- By:
- Publication type:
- Article
Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0134430
- By:
- Publication type:
- Article
Nevirapine or Lamivudine plus Stavudine and Indinavir: Examples of 2-Class versus 3-Class Regimens for the Treatment of Human Immunodeficiency Virus Type 1.
- Published in:
- Clinical Infectious Diseases, 2002, v. 35, n. 9, p. 1096
- By:
- Publication type:
- Article